Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer’s disease, helping clinicians visualise the biological changes associated with the condition and guide decisions about new therapies. Amyloid PET imaging is being used to confirm the presence of amyloid pathology and support treatment decisions for patients receiving anti-amyloid drugs, while tau PET scans can provide additional information about disease progression and prognosis. At the 39th Annual Congress of the European Association of Nuclear Medicine (EANM’26), taking place from 17 to 21 October in Vienna, experts will discuss first experiences with these PET scans in routine clinical use and explore the latest advances in nuclear medicine.

Collagen plays a critical role in keeping heart valves strong, but the heart is surrounded by enzymes designed to break down collagen. So how can heart valves function efficiently decade after decade? A new study shows that the biomechanical tension applied to these valves every time your heart beats plays a key role in protecting the collagen from breaking down.

Experts from the University of Nottingham have discovered how a common genetic mutation disrupts the positioning of a key protein during cell division, revealing a new mechanism behind acute myeloid leukaemia and a potential avenue for future treatment.

Acute myeloid leukaemia (AML) is an aggressive blood cancer that disrupts the production of healthy blood cells. Around one-third of patients carry a mutation in a gene called NPM1, which causes its protein to accumulate in the wrong part of the cell and plays a key role in driving the disease.

Until now, research has largely focused on how the mutated protein moves between the cell's nucleus and the surrounding cytoplasm. But a new study, led by Dr Daniel Booth and Dr Claire Seedhouse at the University of Nottingham's School of Medicine, reveals that what happens during cell division itself is also critical.

The Bronchiectasis and NTM Association today announced plans for an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting for non-cystic fibrosis bronchiectasis (NCFB). This meeting is modeled after the Food & Drug Administration’s (FDA) PFDD public meetings. Drug developers, FDA, and other stakeholders will be in attendance.

Researchers at the University of Veterinary Medicine Vienna, in collaboration with the CeMM Research Center for Molecular Medicine and St. Anna Children’s Cancer Research, have developed a new analytical method that reveals which RNA molecules are involved in cancer-promoting cellular structures. Using this method, the Vienna-based research team identified the RNA molecule Gas5 as an important regulator of NUP98::KDM5A oncogenic condensates, which control gene activity in aggressive forms of acute myeloid leukemia (AML). This new insight may provide important starting points for cancer research and improved patient treatment. The study was published in the renowned journal The EMBO Journal.

The World Series is fast approaching, and the last thing any team or fan wants is to see a player scratched from the lineup because of an injury. A new study led by Laurie Devaney a the University of Connecticut sheds light on the connection between neck mobility and the risk of shoulder and elbow injury in baseball pitchers. This work was published in the Journal of Athletic Training.